Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/CLENE-INC-45490772/news/US-FDA-halt-Studiendaten-von-Clene-fur-ALS-Medikament-fur-unzureichend-45617099/?utm_source=whatsapp&utm_medium=social&utm_campaign=share